Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer
2947.0000 -6.40 (-0.22%)
NSE Jun 16, 2025 15:31 PM
Volume: 84,875
 

2947.00
-0.22%
Systematix Group
collected and processed approximately 21.8 million samples from Dr Lal Path Lab serves approximately 9.9 million patients. According to CRISIL Research, the size of the Indian diagnostic healthcare services industry was approximately Rs.377 billion (US$6.0 billion) in Fiscal Year 2015, and it is projected to grow to over Rs.600 billion (US$9.6 billion) by Fiscal Year 2018. We believe that the increasing prescription of diagnostic tests and services by healthcare providers in India, combined with the growing focus on early detection and prevention of chronic and lifestyle diseases, such as diabetes, hypertension, heart disease and cancer, creates a significant market...
Dr. Lal Pathlabs Ltd. has an average target of 2992.60 from 5 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended